How can immunopathology shape the evolution of parasite virulence?

Trends in Parasitology

Volumn 27, Issue 7, 2011, Pages 300-305

  Long, Gráinne H ^a   Boots, Mike ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

IMMUNE RESPONSE; IMMUNOPATHOLOGY; IN VIVO STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARASITE VIRULENCE; QUALITATIVE ANALYSIS; REVIEW; RNA INTERFERENCE; STREPTOCOCCUS PNEUMONIA; TUBERCULOSIS; VIRUS TRANSMISSION;

ANIMALS; BIOLOGICAL EVOLUTION; HOST-PARASITE INTERACTIONS; HUMANS; PARASITES; PARASITIC DISEASES; PUBLIC HEALTH; VIRULENCE;

EID: 79959367739     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2011.03.012     Document Type: Review

References (61)

1. Margolis E., Levin B.R. The evolution of bacteria-host interactions: virulence and the immune over-response. Introduction to the Evolutionary Biology of Bacterial and Fungal Pathogens 2008, 3-12. ASM Press, Chapter 1. J.-A. Gutteriez, F.M. Baquero (Eds.).
2. Graham A.L., et al. Evolutionary causes and consequences of immunopathology. Annu. Rev. Ecol. Evol. Syst. 2005, 36:337-397.
3. Lipsitch M., Moxon E.R. Virulence and transmissibility of pathogens: what is the relationship?. Trends Microbiol. 1997, 5:31-37.
4. Frank S.A. Models of parasite virulence. Q. Rev. Biol. 1996, 71:37-78.
5. Anderson R.M., May R.M. Coevolution of hosts and parasites. Parasitology 1982, 85:411-426.
6. Day T., et al. Evolution of parasite virulence when host responses cause disease. Proc. R. Soc. Lond. Ser. B: Biol. Sci. 2007, 274:2685-2692.
7. Gilchrist M.A., Sasaki A. Modeling host-parasite coevolution: a nested approach based on mechanistic models. J. Theor. Biol. 2002, 218:289-308.
8. Frank S.A., Schmid-Hempel P. Mechanisms of pathogenesis and the evolution of parasite virulence. J. Evol. Biol. 2007, 21:396-404.
9. Ebert D., Bull J.J. The evolution and expression of virulence. Evolution in Health and Disease 2008, Vol. 2:153-167. Oxford University Press.
10. Donnenberg M.S. Pathogenic strategies of enteric bacteria. Nature 2000, 406:768-774.
11. Casadevall A., Pirofski L.A. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect. Immun. 1999, 67:3703-3713.
12. Brodsky I.E., Medzhitov R. Targeting of immune signalling networks by bacterial pathogens. Nat. Cell Biol. 2009, 11:521-526.
13. de Roode J.C., et al. Virulence-transmission trade-offs and population divergence in virulence in a naturally occurring butterfly parasite. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7489-7494.
14. Mackinnon M.J., Read A.F. Genetic relationships between parasite virulence and transmission in the rodent malaria Plasmodium chabaudi. Evolution 1999, 53:689-703.
15. Antia R., et al. Within-host population dynamics and the evolution and maintenance of microparasite virulence. Am. Nat. 1994, 144:457-472.
16. Antia R., Lipsitch M. Mathematical models of parasite responses to host immune defences. Parasitology 1997, 115:S155-S167.
17. Gandon S., et al. Imperfect vaccines and the evolution of pathogen virulence. Nature 2001, 414:751-756.
18. Alizon S., van Baalen M. Acute or chronic? Within-host models with immune dynamics, infection outcome, and parasite evolution. Am. Nat. 2008, 172:E244-E256.
19. Best A., et al. The implications of coevolutionary dynamics to host-parasite interactions. Am. Nat. 2009, 173:779-791.
20. Best A., et al. The evolution of host-parasite range. Am. Nat. 2010, 176:63-71.
21. Long G.H., et al. Experimental manipulation of immune-mediated disease and its fitness costs for rodent malaria parasites. BMC Evol. Biol. 2008, 8:128.
22. Long G.H., et al. Blockade of TNF receptor 1 reduces disease severity but increases parasite transmission during Plasmodium chabaudi chabaudi infection. Int. J. Parasitol. 2008, 38:1073-1081.
23. Mackinnon M.J., Read A.F. Virulence in malaria: an evolutionary viewpoint. Philos. Trans. R. Soc. B: Biol. Sci. 2004, 359:965-986.
24. Long G.H., Graham A.L. Consequences of immunopathology for pathogen virulence evolution and public health: malaria as a case study. Evol. Appl. 2011, 4:278-291.
25. Cooper A.M., Khader S.A. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 2008, 226:191-204.
26. Rivero A. Nitric oxide: an antiparasitic molecule of invertebrates. Trends Parasitol. 2006, 22:219-225.
27. Belles X. Beyond Drosophila: RNAi in vivo and functional genomics in insects. Annu. Rev. Entomol. 2010, 55:111-128.
28. Sadd B.M., Siva-Jothy M.T. Self-harm caused by an insect's innate immunity. Proc. R. Soc. B: Biol. Sci. 2006, 273:2571-2574.
29. Cornet S., et al. Variation and covariation in infectivity, virulence and immunodepression in the host-parasite association Gammarus pulex-Pomphorhynchus laevis. Proc. Biol. Sci. 2009, 276:4229-4236.
30. Paterson S., Piertney S.B. Frontiers in host-parasite ecology and evolution. Mol. Ecol. 2011, 20:869-871.
31. Jackson J.A., et al. The analysis of immunological profiles in wild animals: a case study on immunodynamics in the field vole Microtus agrestis. Mol. Ecol. 2011, 20:893-909.
32. Grear D.A., et al. Does elevated testosterone result in increased exposure and transmission of parasites?. Ecol. Lett. 2009, 12:528-537.
33. Alizon S., et al. Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future. J. Evol. Biol. 2009, 22:245-259.
34. Knodler L.A., et al. Pathogenic trickery: deception of host cell processes. Nat. Rev. Mol. Cell Biol. 2001, 2:578-588.
35. Sacks D., Sher A. Evasion of innate immunity by parasitic protozoa. Nat. Immunol. 2002, 3:1041-1047.
36. Everts B., et al. COX-2-Specific inhibitors - the emergence of a new class of analgesic and anti-inflammatory drugs. Clin. Rheumatol. 2000, 19:331-343.
37. Read A.F. The evolution of virulence. Trends Microbiol. 1994, 2:73-76.
38. Ewald P.W. Host-parasite relations, vectors and the evolution of disease severity. Annu. Rev. Ecol. Syst. 1983, 14:465-485.
39. Craib K.J., et al. Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection. J. Infect. Dis. 1997, 176:798-800.
40. Meunier P.C., et al. Pathogenesis of canine parvovirus enteritis: the importance of viremia. Vet. Pathol. 1985, 22:60-71.
41. Turner C.M., et al. Replication, differentiation, growth and the virulence of Trypanosoma brucei infections. Parasitology 1995, 111:289-300.
42. van der Goot J.A., et al. Comparison of the transmission characteristics of low and high pathogenicity avian influenza A virus (H5N2). Epidemiol. Infect. 2003, 131:1003-1013.
43. Ferguson H.M., et al. Mosquito mortality and the evolution of malaria virulence. Evolution 2003, 57:2792-2804.
44. Fraser C., et al. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17441-17446.
45. Fenner F., Ratcliffe R.N. Myxomatosis 1965, Cambridge University Press.
46. Mackinnon M.J., et al. Virulence in rodent malaria: host genotype by parasite genotype interactions. Infect. Genet. Evol. 2002, 1:287-296.
47. Levin B.R., Bull J.J. Short-sighted evolution and the virulence of pathogenic microorganisms. Trends Microbiol. 1994, 2:76-81.
48. Weiss R.A. Virulence and pathogenesis. Trends Microbiol. 2002, 10:314-317.
49. Day T. On the evolution of virulence and the relationship between various measures of mortality. Proc. Biol. Sci. 2002, 269:1317-1323.
50. Waitumbi J.N., et al. Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Blood 2000, 95:1481-1486.
51. Day T. Virulence evolution and the timing of disease life-history events. Trends Ecol. Evol. 2003, 18:113-118.
52. Osnas E.E., Dobson A.P. Evolution of virulence when transmission occurs before disease. Biol. Lett. 2010, 6:505-508.
53. Sriskandan S., et al. Streptococcus pyogenes: insight into the function of the streptococcal superantigens. Int. J. Biochem. Cell Biol. 2007, 39:12-19.
54. Larkin E.A., et al. Staphylococcus aureus: the toxic presence of a pathogen extraordinaire. Curr. Med. Chem. 2009, 16:4003-4019.
55. Tuomanen E., et al. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 1985, 151:859-868.
56. Dao D.N., et al. Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect. Immun. 2004, 72:2067-2074.
57. Reichler M.R., et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002, 287:991-995.
58. Carrero J.A., et al. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 2004, 200:535-540.
59. Carrero J.A., et al. Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule. J. Immunol. 2004, 172:4866-4874.
60. Luder C.G., Gross U. Apoptosis and its modulation during infection with Toxoplasma gondii: molecular mechanisms and role in pathogenesis. Curr. Top. Microbiol. Immunol. 2005, 289:219-237.
61. Abrami L., et al. Anthrax toxin: the long and winding road that leads to the kill. Trends Microbiol. 2005, 13:72-78.